Buffington Mohr McNeal Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$3.03M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$1.09M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$825K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$752K |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$667K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teleflex
TFX
|
+$1.65M |
| 2 |
VWR
VWR Corporation
VWR
|
+$1.22M |
| 3 |
CME Group
CME
|
+$570K |
| 4 |
GE Aerospace
GE
|
+$340K |
| 5 |
AT&T
T
|
+$291K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.84% |
| 2 | Industrials | 12.24% |
| 3 | Technology | 8.66% |
| 4 | Financials | 6.62% |
| 5 | Consumer Staples | 4.73% |
Similar funds
Buffington Mohr McNeal's Q2 2017 Portfolio in Review
As of Q2 2017, Buffington Mohr McNeal held 139 positions worth $253M, up 11% from $227M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Buffington Mohr McNeal deployed $18.5M of net new capital in Q2 2017, opening 30 new positions and adding to 54 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 11,867 shares worth $1.1M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Teleflex, an estimated $1.65M trimmed.
- Buffington Mohr McNeal's largest Q2 2017 buy was Invesco S&P 500 Equal Weight ETF: 11,867 shares worth $1.1M.
- Buffington Mohr McNeal added most to Thermo Fisher Scientific in Q2 2017, an estimated $3.03M increase.
- Buffington Mohr McNeal's biggest Q2 2017 reduction was Teleflex, cutting an estimated $1.65M.
- Buffington Mohr McNeal fully exited CME Group in Q2 2017, selling an estimated $570K.
- Buffington Mohr McNeal's ten largest holdings make up 36% of its $253M portfolio in Q2 2017.
- Buffington Mohr McNeal opened 30 new positions and closed 5 in Q2 2017.
- Buffington Mohr McNeal's portfolio value rose 11% quarter-over-quarter to $253M.
Based on Buffington Mohr McNeal's 13F filing for Q2 2017, filed 13 Jul 2017.